Records 1-4 (of 4 Records) |
Query Trace: BRCA1[original query]>>BRCA1[Gene] |
---|
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic. Benusiglio Patrick R, et al. European journal of medical genetics 2020 11 0. 104098 |
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA. Barata Pedro, et al. Journal for immunotherapy of cancer 2020 0 0. (2) |
Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019. Vetter Monica Hagan, et al. American journal of obstetrics and gynecology 2020 5 0. |
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic. Minucci Angelo, et al. Molecular biology reports 2020 5 0. |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 23, 2024
- Content source: